LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the fourth quarter and fiscal year ended December 30, 20…
Author: Business Wire
Iowa Department for the Blind Selects Tyler Technologies’ Vocational Rehabilitation Solution
PLANO, Texas–(BUSINESS WIRE)—- $TYL #TylerTech–Tyler Technologies has signed an agreement with the Iowa Department for the Blind for Tyler’s Vocational Rehabilitation solution.
Napoli Shkolnik Files Complaint Against Manufacturers of Artificial Tear Products Linked to Bacterial Infections
NEW YORK–(BUSINESS WIRE)– #NapoliShkolnik–Napoli Shkolnik filed a lawsuit today on behalf of Marc Sherman against Ezricare LLC; Ezrirx LLC; Delsam Pharma LLC and others.
Iveric Bio Announces FDA Accepts New Drug Application and Grants Priority Review for Avacincaptad Pegol for the Treatment of Geographic Atrophy
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio announced that the U.S. FDA completed its filing review and accepted the company’s New Drug Application (NDA) for avacincaptad pegol (ACP).
Aura Biosciences Announces Positive Interim Phase 2 Safety and Efficacy Data of Belzupacap Sarotalocan (Bel-sar) for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma with Suprachoroidal Administration
BOSTON–(BUSINESS WIRE)–Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the presentation of…
Shoulder to Shoulder Foundation Receives $25,000 Donation from The Gem Foundation
HAUPPAUGE, N.Y.–(BUSINESS WIRE)–Shoulder to Shoulder Foundation, a non-profit organization addressing the unmet needs of individuals and their families affected by poverty, today announced the generous $25,000 donation from The Gem Foundation. The Ge…
Celanese Announces a Research Agreement with Johns Hopkins University to Advance Sustained Ocular Drug Delivery to the Suprachoroidal Space
DALLAS–(BUSINESS WIRE)—- $CE–Celanese Announces a Research Agreement with Johns Hopkins University to Advance Sustained Ocular Drug Delivery to the Suprachoroidal Space
National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2022 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its fourth quarter and fiscal 2022 financial results before the market opens on Wednesday, March 1, 2023. The Company will host …
Glaukos Announces Participation in the Citi Healthcare Conference
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Harrow Launches Next-Generation Compounded Atropine Formulations
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the launch of its patent-pending, next-generation compounded Atropine formulations, which are now available through Harro…
Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer and Chair of the Board of Directors, Effective March 6, 2023
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, announced the appointment of Brent Saunders as …
Global Ophthalmic Devices Technologies and Markets 2023: Technological Advancements and Increasing Government Initiatives Drive Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. In recent years there have been significant advances in the development of ophthalmic devices and surgical pr…
Designed with purpose — The Global Mercy® arrives in Dakar ready to serve the people of Senegal and The Gambia with surgical expertise and training
DAKAR, Senegal–(BUSINESS WIRE)–The newest Mercy Ship, the Global Mercy® arrived in Dakar, Senegal on February 14, 2023. While the ship hosted surgical training in Senegal in 2022, this year marks the first time that specialized surgeries will take pl…
Dankzij EnChroma brillen kunnen kleurenblinde bezoekers toch de kleurrijke kunst in het Van Gogh Museum ervaren
AMSTERDAM, Nederland & BERKELEY, Californië–(BUSINESS WIRE)–EnChroma kondigde vandaag aan dat kleurenblinde bezoekers nu de kleurrijke meesterwerken in het Van Gogh Museum in meer verzadigde kleuren kunnen waarnemen. Als onderdeel van de missie van h…
LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced its preliminary unaudi…
Colour Blind Guests to the Van Gogh Museum to Experience Art in Colour with EnChroma Glasses
AMSTERDAM, The Netherlands & BERKELEY, Calif.–(BUSINESS WIRE)– #enchroma–Colour blind visitors to the Van Gogh Museum can now enjoy the colourful masterpieces of Van Gogh by borrowing EnChroma colour blind glasses.
Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
GENEVA–(BUSINESS WIRE)–Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
GENEVA–(BUSINESS WIRE)–Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
Novaliq计划于2023年7月在欧盟提交CyclASol®用于治疗干眼症的上市许可申请
德国海德堡和美国马萨诸塞州剑桥–(BUSINESS WIRE)–(美国商业资讯)–Novaliq是一家生物制药公司，专注于基于独家EyeSol®无水技术的同类首创一流眼科治疗药物。公司今天宣布计划提交CyclASol®（环孢素眼药水）的上市许可申请(MAA)。这将是欧盟首款用于治疗干眼症(DED)的抗炎产品。 欧洲药品管理局(EMA)的人用药品委员会(CHMP)判定CyclASol®有资格接受集中程序的审查，以获得欧盟经济区(EEA)的上市许可。2022年12月，EMA在其答复中指出，根据No…
New Phase III Data Show Genentech’s Vabysmo Rapidly Improved Vision and Reduced Retinal Fluid in People With Retinal Vein Occlusion (RVO)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive new data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab-svoa) in macular …